SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029794
Filing Date
2020-06-18
Accepted
2020-06-18 16:12:36
Documents
16
Period of Report
2020-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kldo-8k_20200615.htm   iXBRL 8-K 75985
2 EX-10.1 kldo-ex101_15.htm EX-10.1 1229402
3 GRAPHIC gbj3qfmj3djs000001.jpg GRAPHIC 6904
4 GRAPHIC gbj3qfmj3djs000002.jpg GRAPHIC 847
5 GRAPHIC gbj3qfmj3djs000003.jpg GRAPHIC 847
  Complete submission text file 0001564590-20-029794.txt   1593965

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kldo-20200615.xsd EX-101.SCH 5772
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20200615_lab.xml EX-101.LAB 19468
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20200615_pre.xml EX-101.PRE 11626
11 EXTRACTED XBRL INSTANCE DOCUMENT kldo-8k_20200615_htm.xml XML 3539
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 20972673
SIC: 2836 Biological Products, (No Diagnostic Substances)